RH ou Marketing?Demandez votre compte employeur gratuit
Pfizer Compagnie réclamée

Pfizer Culture d’entreprise

Score de culture

Ce score est dérivé des évaluations et avis des employés
4.1/5
La Culture Globale de Pfizer est notée B

Dimensions culturelles les mieux cotées

Score du PDG

Top 20 %Top 20 % d’entreprises de taille similaire sur Comparably
Albert Bourla Pfizer's CEO
Albert Bourla
74 /100

Pfizer Mission, vision et valeurs

Les objectifs de votre entreprise sont-ils clairs et y investissez-vous?

Déclaration de mission

At Pfizer, we innovate every day to make the world a healthier place. It was the vision of Charles Pfizer at the very beginning and it holds true today in everything we do. From scientific discovery to breakthrough products to our essential partnerships around the world, we're committed to quality healthcare for everyone. Because every individual matters.

Énoncé de vision

Pfizer vision statement is Innovate to bring therapies to patients that significantly improve their lives.

Pfizer Coup d’oeil sur la culture

323 des employés de chez Pfizer ont examiné Pfizer dans diverses dimensions culturelles, en donnant leur avis sur des sujets allant des évaluations des dirigeants au rythme de travail. La dernière évaluation date d'il y a 2 journées.

Globalement, les employés de 323 Pfizer donnent à leur direction une note de B, ou Top 30% entreprises de taille similaire sur Comparably. Cela inclut des évaluations spécifiques de leur équipe de direction, de leur chef de la direction et de leur gestionnaire.

Employés à Pfizer sont satisfaits de leur rémunération totale à Pfizer , qui comprend une combinaison de rémunération, d’actions et d’équité, ainsi que d’avantages.

Dans l’ensemble, les employés de Pfizer sont généralement satisfaits de leur équipe. 323 Les participants notent la qualité de leurs collègues à B . La majorité croit que les réunions de Pfizer sont efficaces et la majorité se réjouit d’interagir avec ses collègues.

La majorité des employés de Pfizercroient que l'environement chez Pfizer est positif. La plupart des participants croient que le rythme de travail chez Pfizer est confortablement rapide . Envirion 56% des employés chez Pfizer travaillent 8 heures ou moins, pendant que 10 % d’entre eux ont une journée extrêmement longue - plus de douze heures.

Dans l’ensemble, les employés de Pfizer sont généralement satisfaits, basé sur de leurs notes globales des perspectives futures, de la perception des clients et de leur enthousiasme à l’œuvre.

Informations sur la société

Adresse
235 East 42nd Street
New York City, NY 10017
United States of America
Site Internet
www.pfizer.com
Fondé
1848

Description de l’entreprise

Pfizer, a bio-pharmaceutical company, develops and manufactures human and veterinary medicines, as well as consumer healthcare products.

Dirigeants clés

Nom et titre
Bio
Albert Bourla  CEO / President
Albert Bourla
CEO / President
Albert Bourlasert en tant que CEO / President de Pfizer .
Mikael Dolsten M.D., Ph.D.  President of Worldwide Research & Development and Executive VP
Mikael Dolsten M.D., Ph.D.
President of Worldwide Research & Development and Executive VP
Dr. Mikael Dolsten, MD, Ph.D., has been the President of Worldwide Research and Development at Pfizer Inc. since December 2010 and has been its Executive VP since June 13, 2017. Dr. Dolsten serves as an Executive Vice President of Pfizer Inc. Dr. Dolsten also serves as a Member of Pfizer Executive Leadership Team. Dr. Dolsten serves as the President of Worldwide Research and Development at Pfizer Limited. Prior to joining Pfizer in 2009, he served as Senior Vice President of Wyeth and President of Wyeth Research, where he was responsible for the global R&D division and led scientists across the US, Europe and Asia. Before joining Wyeth, he served as an Executive Vice President at Boehringer Ingelheim, where he was responsible for worldwide research including activities at R&D sites in the US, Canada, Germany, Italy, Austria and Japan. He served as Head of Corporate Division Pharma Research/Discovery at Boehringer Ingelheim with responsible for approximately 1400 discovery scientists and world-wide research in respiratory, immunology/inflammation, metabolic disease, CNS/pain, oncology and cardiovascular therapies. Dr. Dolsten was a Partner at OrbiMed Advisors, L.L.C. He held various senior R&D management positions including: Head of Preclinical Research Oncology/Immunology at Pharmacia & Upjohn, Lund and Head of Preclinical R&D, Vice President of Respiratory and Inflammation at Astra Draco, Lund. In addition, he gained leadership experience from five large-scale M&A transactions. He served as the President of BioTherapeutics Research & Development at Pfizer Inc. from October 2009 to May 2010 and served as its Senior Vice President from May 2010 to December 2010. Prior to joining Boehringer Ingelheim in 2003, Dr. Dolsten was responsible for integrating several areas of AstraZeneca Discovery post-merger. He also served as Global Vice President/Head of Cardiovascular/Metabolic & Gastrointestinal Discovery at AstraZeneca. Dr. Dolsten has spent approximately seventeen years in the pharmaceutical Industry. He has been Chairman, Translational Advisory Board of Apple Tree Partners since 2016. Dr. Dolsten has been an Independent Director at Karyopharm Therapeutics Inc. since March 31, 2015. He serves as a Member of Translational Advisory Board at Apple Tree Partners. He serves as a Member of MDL Scientific Advisory Board at Elsevier B.V. He served as a Director of Receptos, Inc. He is a Member of the Biomedical Advisory Council of The Pharmaceutical Research and Manufacturers of America (PhRMA) and serves on the PhRMA Foundation Board of Directors. He has been a Board Member of a Swedish Business School for Innovation and Chamber of Commerce. He is a Governor of the New York Academy of Sciences. He was appointed as Adjunct Professor in Immunology at the Medical Faculty in Lund, Sweden. He was Associate Professor at Lund University since 1989 and Adjunct Professor in Cell and Molecular Biology since 1996. Dr. Dolsten is a named inventor on several patents and has published approximately 150 articles in international journals, with particular contributions in areas such as molecular cell biology, immunology and oncology. He earned his Ph.D. in Tumor Immunology and M.D. from the University of Lund in Sweden. He also studied Virology and Cell Biology at the Weizmann Institute in Israel.
John D. Young  Group President of Pfizer Innovative Health
John D. Young
Group President of Pfizer Innovative Health
Mr. John D. Young has been the Group President of Pfizer Innovative Health at Pfizer Inc. since January 1, 2018 and served as its Group President of Pfizer Essential Health from June 2016 to January 1, 2018. Mr. Young is a Director of Johnson Controls International plc from December 2017. He served as a Group President of Global Established Pharma Business at Pfizer Inc. from January 1, 2014 to June 2016. Mr. Young served as President and General Manager of Primary Care Business Unit at Pfizer Inc. from June 1, 2012 to December 2013 and U.K. Country Manager from 2007 until 2009. He served as Regional President of Europe and Canada for The Primary Care Business at Pfizer Inc. from 2009 to June 1, 2012. Over his 25-year career with Pfizer, he served a number of commercial positions with the company, including country and regional management roles in Australia/New Zealand and the United Kingdom. He is a scientist by training and has deep knowledge of the company's innovative biopharmaceutical portfolio having led the commercial and clinical development of medicines in key therapeutic areas including cardiovascular disease, diabetes and pain. Mr. Young received a BSc in Biological Science from Glasgow University and an MBA from Strathclyde Graduate Business School.
Frank A. D'Amelio  CFO & Executive VP of Business Operations
Frank A. D'Amelio
CFO & Executive VP of Business Operations
Frank A. D'Amelio has served as a Director of Humana Inc. since September 2003. He is Executive Vice President, Business Operations and Chief Financial Officer of Pfizer Inc., having held this position since December 2010, and having served as Chief Financial Officer since September 2007. Prior to that, Mr. D'Amelio was Senior Executive Vice President of Integration and Chief Administrative Officer at Alcatel-Lucent from December 2006 to August 2007, and Chief Operating Officer of Lucent Technologies Inc. from February 2006 to November 2006. From May 2001 until January 2006, he was Executive Vice President, Administration and Chief Financial Officer of Lucent. Mr. D'Amelio also serves on the Board of Directors of Zoetis, Inc. and on the board of the Independent College Fund of New Jersey.
Annette Doherty  Head of Worldwide Pharmaceutical Sciences
Annette Doherty
Head of Worldwide Pharmaceutical Sciences
Dr. Annette Doherty has been Head of Worldwide Pharmaceutical Sciences of Pfizer Inc., since May 2005.
Kathrin U. Jansen  Senior Vice President & Head of Vaccine Research & Development
Kathrin U. Jansen
Senior Vice President & Head of Vaccine Research & Development
Dr. Kathrin U. Jansen, Ph.D. has been Senior Vice President of Vaccine Research & Development at Pfizer Inc. since June 01, 2015. Dr. Jansen served as Senior Vice President of Early Phase Programs of Vaccine Research at Wyeth LLC. Dr. Jansen served as Senior Vice President of Research and Development and Chief Scientific Officer of VaxGen Inc., from October 19, 2004 to July 29, 2006. Dr. Jansen lead an organization of approximately 550 colleagues comprised of clinicians, vaccine process/analytical/and formulation development, and other laboratory scientists. Dr. Jansen joined VaxGen in October 2004 after having served as Executive Director of Microbial Vaccine Research for Merck Research Laboratories. At Vaxgen, Dr. Jansen leads a team of more than 40 scientists and related personnel in developing Vaxgen's existing investigational vaccines, as well as evaluating and developing new product candidates. Dr. Jansen was the scientific leader of the team that successfully developed Merck's Phase III human papillomavirus (HPV) vaccine candidate to prevent genital warts and cervical cancer. Additionally, she was responsible for several bacterial vaccine programs at Merck. Dr. Jansen also headed the clinical assay laboratory responsible for the development and validation of new assays and for the clinical testing of all existing Merck accines and vaccine candidates. Dr. Jansen joined Merck in 1992 as a research fellow and advanced through a series of positions with increasing responsibility. Prior to Merck, she served from 1989 to 1992 as a research scientist at the Glaxo Institute for Molecular Biology, where she studied the structure and function of a low affinity receptor for IgE (CD23). Prior to her career in industry, Dr. Jansen held research positions at Cornell University and Institut fur Mikrobiologie, Marburg, Germany. She is an author on 53 scientific articles and the inventor on seven issued patents and numerous patent applications related to vaccine research and development. She holds a Ph.D. in Microbiology, with a minor in Biochemistry and Genetics and an undergraduate degree in Biology from Philipps-Universitat, Marburg, Germany.
Hugh Donnelly  Chief Internal Auditor
Hugh Donnelly
Chief Internal Auditor
Mr. Hugh Donnelly serves as the Chief Internal Auditor of Pfizer Inc. and served as its Vice President of Corporate Audit. Mr. Donnelly assumed this position in July, 2002 and is responsible for leading 120 audit professionals primarily based in New York, New Jersey, Connecticut, Pennsylvania, Mumbai and Dublin. Corporate Audit provides independent, Pan-Pfizer corporate regulatory audit and oversight of processes and systems spanning its operating model including: discovery, development, manufacturing, commercial sales & marketing activities, finance and information technology. Previously, he was Assistant Controller, Pfizer Inc. with responsibility for Pfizer's Financial Shared Services. He served US Treasury operations and European finance roles in Corporate Treasury. Hugh joined Pfizer as Controller of the acquired SmithKline Beecham Animal Health business in 1995. Hugh has held numerous other financial positions in commercial operations, manufacturing and corporate finance over a 25+ year career in the pharmaceutical industry. Hugh is CPA who started his career with PriceWaterhouse Coopers/Coopers & Lybrand. He holds a BS in Accounting from Villanova University.
Susan Silbermann  President of Global Vaccines Business and General Manager of Global Vaccines Business
Susan Silbermann
President of Global Vaccines Business and General Manager of Global Vaccines Business
Susan Silbermann has been President of Global Vaccines Business and General Manager of Global Vaccines Business at Pfizer Inc., since January 1, 2014. Susan Silbermann serves as the Regional President, Latin America at Emerging Markets Business Unit of Pfizer Inc. Susan Silbermann serves as a Member of the Advisory Board at Catalyst Inc.
Loretta V. Cangialosi  Senior Vice President and Controller
Loretta V. Cangialosi
Senior Vice President and Controller
Ms. Loretta V. Cangialosi has been a Senior Vice President and Controller of Pfizer, Inc since February 1993 and served as its Vice President. Ms. Cangialosi serves as a Member of Standing Advisory Group at Public Company Accounting Oversight Board (PCAOB).
Michael Vincent M.D., Ph.D.  Chief Scientific Officer of Inflammation & Immunology Research Unit and Senior Vice President
Michael Vincent M.D., Ph.D.
Chief Scientific Officer of Inflammation & Immunology Research Unit and Senior Vice President
Dr. Michael Vincent, M.D., Ph.D. has been Senior Vice President and Chief Scientific Officer of Inflammation and Immunology Research Unit at Pfizer Inc. since May 2016. Since joining Pfizer in 2011, Dr. Vincent served numerous scientific leadership roles, served as Clinical Head for Pharmatherapeutics and Biotherapeutics. Before joining Pfizer, Dr. Vincent served several positions within Medical Sciences at Amgen. He also served as a staff physician at Harvard University. Dr. Vincent earned his Ph.D. and M.D. degrees from Indiana University. He completed his residency and began his post-doctoral training at the University of Vermont and ultimately completed at Harvard University.

Leaders RH

Nom et titre
Bio
Pamela Puryear  Senior Vice President, Chief Talent Officer
Pamela Puryear
Senior Vice President, Chief Talent Officer
Pamela Puryear sert en tant que Senior Vice President, Chief Talent Officer de .
Barbara Elsden  VP Human Resources
Barbara Elsden
VP Human Resources
Barbara Elsden sert en tant que VP Human Resources de .
Kristin Papesh  Vice President, Human Resources
Kristin Papesh
Vice President, Human Resources
Kristin Papesh sert en tant que Vice President, Human Resources de .
Hong Lu  Vice President, Global HR Operations
Hong Lu
Vice President, Global HR Operations
Hong Lu sert en tant que Vice President, Global HR Operations de .
Rachel Cheeks-Givan  Global Director Diversity & Inclusion
Rachel Cheeks-Givan
Global Director Diversity & Inclusion
Rachel Cheeks-Givan sert en tant que Global Director Diversity & Inclusion de .
Steven Burdette  Director, Diversity & Inclusion
Steven Burdette
Director, Diversity & Inclusion
Steven Burdette sert en tant que Director, Diversity & Inclusion de .
Dan Miller  Director, HR Business Technology (Global Operations and M&A Lead)
Dan Miller
Director, HR Business Technology (Global Operations and M&A Lead)
Dan Miller sert en tant que Director, HR Business Technology (Global Operations and M&A Lead) de .
Kim Robbins  Director, Culture and Employee Engagement
Kim Robbins
Director, Culture and Employee Engagement
Kim Robbins sert en tant que Director, Culture and Employee Engagement de .
Gaurav Jain  Director Global HR Reporting, Analytics & Security
Gaurav Jain
Director Global HR Reporting, Analytics & Security
Gaurav Jain sert en tant que Director Global HR Reporting, Analytics & Security de .
Janice Beauchamp  VP, Human Resources - Medical, Corporate Strategy and HR Business Development
Janice Beauchamp
VP, Human Resources - Medical, Corporate Strategy and HR Business Development
Janice Beauchamp sert en tant que VP, Human Resources - Medical, Corporate Strategy and HR Business Development de .
Catherine Dimes  Vice President, Global Talent Acquisition
Catherine Dimes
Vice President, Global Talent Acquisition
Catherine Dimes sert en tant que Vice President, Global Talent Acquisition de .
Elaine Cunningham  Sr. Director, Human Resources HR Lead
Elaine Cunningham
Sr. Director, Human Resources HR Lead
Elaine Cunningham sert en tant que Sr. Director, Human Resources HR Lead de .
Thomas Kirchgasser  Vice President Human Resources - Pfizer Global Supply ( Manufacturing)
Thomas Kirchgasser
Vice President Human Resources - Pfizer Global Supply ( Manufacturing)
Thomas Kirchgasser sert en tant que Vice President Human Resources - Pfizer Global Supply ( Manufacturing) de .
Denny Glasper  Director - Human Resources
Denny Glasper
Director - Human Resources
Denny Glasper sert en tant que Director - Human Resources de .
Michael OConnor  Director, HR Global Operations, Vendor Management
Michael OConnor
Director, HR Global Operations, Vendor Management
Michael OConnor sert en tant que Director, HR Global Operations, Vendor Management de .
Bob Matts  VP, HR, Business Platforms
Bob Matts
VP, HR, Business Platforms
Bob Matts sert en tant que VP, HR, Business Platforms de .
Scott White  Director Human Resources
Scott White
Director Human Resources
Scott White sert en tant que Director Human Resources de .
Neena Dosanj  Senior Director, Pfizer Consumer Healthcare Human Resources Lead
Neena Dosanj
Senior Director, Pfizer Consumer Healthcare Human Resources Lead
Neena Dosanj sert en tant que Senior Director, Pfizer Consumer Healthcare Human Resources Lead de .
Sander Beer  Vice President Human Resources - Worldwide R&D
Sander Beer
Vice President Human Resources - Worldwide R&D
Sander Beer sert en tant que Vice President Human Resources - Worldwide R&D de .
Jennifer Bartell  Director, HR Global Operations
Jennifer Bartell
Director, HR Global Operations
Jennifer Bartell sert en tant que Director, HR Global Operations de .
Lucille Askes  Manager, North America Talent Acquisition, Global Science
Lucille Askes
Manager, North America Talent Acquisition, Global Science
Lucille Askes sert en tant que Manager, North America Talent Acquisition, Global Science de .
Dana Allison  Director, Human Resources
Dana Allison
Director, Human Resources
Dana Allison sert en tant que Director, Human Resources de .
Lisa Marin  Senior Director, Human Resources - Pfizer Essential Health, North America
Lisa Marin
Senior Director, Human Resources - Pfizer Essential Health, North America
Lisa Marin sert en tant que Senior Director, Human Resources - Pfizer Essential Health, North America de .
Erin Clark  Director, Human Resources
Erin Clark
Director, Human Resources
Erin Clark sert en tant que Director, Human Resources de .
Flor Battilana  Sr. Director Human Resources - Executive Operations
Flor Battilana
Sr. Director Human Resources - Executive Operations
Flor Battilana sert en tant que Sr. Director Human Resources - Executive Operations de .
Jackie Goldschmidt  Director, Global Talent Acquisition - Pfizer Global Supply (PGS)
Jackie Goldschmidt
Director, Global Talent Acquisition - Pfizer Global Supply (PGS)
Jackie Goldschmidt sert en tant que Director, Global Talent Acquisition - Pfizer Global Supply (PGS) de .
Darren DeLuca  Manager, US Recruitment Outreach (Veterans & People with Disabilities)
Darren DeLuca
Manager, US Recruitment Outreach (Veterans & People with Disabilities)
Darren DeLuca sert en tant que Manager, US Recruitment Outreach (Veterans & People with Disabilities) de .
Tania ODonnell  Senior Leader, Global Talent Acquisition- Worldwide Research & Development
Tania ODonnell
Senior Leader, Global Talent Acquisition- Worldwide Research & Development
Tania ODonnell sert en tant que Senior Leader, Global Talent Acquisition- Worldwide Research & Development de .
Amora Carlotta  Human Resources Director
Amora Carlotta
Human Resources Director
Amora Carlotta sert en tant que Human Resources Director de .
Nila Nath  Senior Talent Acquisition Specialist - Pfizer Global Supply
Nila Nath
Senior Talent Acquisition Specialist - Pfizer Global Supply
Nila Nath sert en tant que Senior Talent Acquisition Specialist - Pfizer Global Supply de .

Pfizer Avis des employés

Avis positifs
69%
69%
31%
Commentaires constructifs
31%

Commentaires positifs des employés

Qu’avez-vous le plus aimé du procédé d’entretien?

Behavioral and leadership questions, scenario based, less technical

Qu’est-ce qui vous rend le plus heureux au travail?

Flexible, less stress, happiness, joyous

Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?

Friendly, great atmosphere, joyous, innovative, interesting

Commentaires constructifs des employés

Pourquoi vous sentez-vous sous-évalué et qu’est-ce qui vous rassurerait par rapport à votre rémunération?

Atleast 10percent increase than my current pay

getting more the share of the profits

De quoi l’équipe de direction a-t-elle besoin pour s’améliorer?

Paying attention and listening to their SMEs

Un jour dans la vie
Un jour dans la vie
Les employés de Pfizer travaillent généralement 9.3 heures par jour
Heures de travail
Un jour dans la vie
Les employés de chez Pfizer signalent que le rythme de travail est confortablement rapide
Rythme de travail
Un jour dans la vie
Au cours d’une journée normale, les employés de Pfizer ont 2 réunions
Des réunions
Un jour dans la vie
82% des employés de chez Pfizer sont impatients d’interagir avec leur équipe tous les jours
Collègues de travail
Un jour dans la vie
Les employés de Pfizer prennent le plus souvent 20-30 congés payés et de congés de maladie chaque année
Avantages
Un jour dans la vie
62% des employés chez Pfizer déclarent qu’ils sont satisfaits de leur équilibre travail-vie personnelle
L’équilibre travail-vie
Un jour dans la vie
Les employés de Pfizer reçoivent généralement des commentaires précieux sur la façon de s’améliorer au travail une fois par trimestre
Retour d’information
Un jour dans la vie
74% des employés de Pfizer appellent leur environnement de travail positif
Environnement

Laissez Pfizer savoir que vous voulez travailler là-bas

Dîtes à Pfizer que vous êtes intéressé à travailler dans l'entreprise tout en maintenant votre identité personnelle anonyme. Comparably donnera à Pfizer l’occasion de vous embaucher. Quand un poste qui vous convient s'ouvrira, nous ferons le match.

Curieux de savoir à quoi ressemble de travailler chez Pfizer ?

Demandez anonymement aux employés de Pfizer n’importe quelle question

Posez une question anonyme

Q&A Anonyme avec des employés de chez Pfizer

Dernières questions / réponses

Top
30%

Score de direction

dans le Top 30 % d’entreprises de taille similaire sur Comparably

TendanceLe score de cette catégorie a eu tendance à augmenter % depuis le mois dernier
69
sur 100
Évaluation de la direction?
74
sur 100
Évaluation du PDG?
71
sur 100
Évaluation du gestionnaire?
Top
20%

Score de compensation

dans le Top 20 % d’entreprises de taille similaire sur Comparably

TendanceLe score de cette catégorie a eu tendance à augmenter % depuis le mois dernier
Bien payé?
Satisfait des avantages?
Top
35%

Score d’équipe

dans le Top 35 % d’entreprises de taille similaire sur Comparably

TendanceLe score de cette catégorie a eu tendance à augmenter % depuis le mois dernier
Interaction avec un collègue?
76
sur 100
Qualité des collègues?
Top
40%

Score de l’environnement

dans le Top 40 % d’entreprises de taille similaire sur Comparably

TendanceLe score de cette catégorie a eu tendance à augmenter % depuis le mois dernier
7 ou moins
8%
8
48%
10
27%
12
7%
Plus de 12
10%
Heures de travail par jour?
Extrêmement rapide
24%
Confortablement rapide
40%
Modéré
24%
Un peu lent
5%
Bureaucratique
7%
Rythme au travail?
Positif
74%
Négatif
26%
Environnement de travail positif?
Top
30%

Score Outlook

dans le Top 30 % d’entreprises de taille similaire sur Comparably

TendanceLe score de cette catégorie a eu tendance à augmenter % depuis le mois dernier
78
sur 100
Perspectives d’avenir?
Fantastique
20%
Bien
46%
Neutre
22%
Mal
10%
Terrible
2%
Perception du client?
Excité d’aller au travail?

Pfizer Visa H1B

En 2019, Pfizer a appliqué pour 82 Visas H1B. Des permis de travail demandés, 74% ont été approuvés.

Résultat de la demande de permis de travail

82
Total appliqué
  • 74% Accordé (61 sur 82)
  • 2% Refusé (2 sur 82)
  • 0% Retiré La demande a été retirée par l’employeur avant l’approbation / le rejet ( sur 82)
  • 23% Certifié retiré La demande a été approuvée puis retirée par l’employeur (19 sur 82)

Ces données ont été calculées à l’aide de données provenant de sources publiques à partir de données de performance OFLC.

Score de genre Comment positivement les femmes évaluent leur expérience globale à Pfizer

Top
50%

Pfizer se classe actuellement dans le Top 50% d’entreprises de taille similaire sur Comparably

Score de diversité Comment positivement les minorités évaluent leur expérience globale à Pfizer

Top
50%

Pfizer se classe actuellement dans le Top 50% d’entreprises de taille similaire sur Comparably

eNPS

Score de promoteur net suit le score global de vos employés à cette question: "Sur une échelle de 1 à 10, êtes-vous susceptible de recommander de travailler dans votre entreprise à un ami?"
Top 25 %Top 25 % d’entreprises de taille similaire sur Comparably
22
Score eNPS
49%Promoters
24%Passives
27%Detractors

Pfizer Vidéo de culture

Voir tous les médias

Vidéo des concurrents de Pfizer

Pfizer Les concurrents

  1. 1st
    Johnson & Johnson
    76 / 100
  2. 2nd
    AbbVie
    76 / 100
  3. 3rd
    Roche
    75 / 100
  4. 4th
    Merck
    74 / 100
  5. 5th
    Pfizer
    72 / 100

Avantages et bénéfices

Santé
Assurance dentaire
Assurance vision
Assurance santé

Vous connaissez quelqu’un qui travaille chez Pfizer ?

Envoyez-leur une invitation pour évaluer la culture de l’entreprise.

Envoyer anonymement une invitation

×
Évaluez votre entreprise